Skip to main content

Want a detailed portfolio tracker?

Galecto (GLTO) P/E (2020 - 2026)

Galecto (GLTO) P/E from Oct 29, 2020 to Jul 21, 2026. The TTM Galecto (GLTO) P/E is -0.23. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Galecto (GLTO)

YearP/EChange
2026-0.23+33.69%
2025-0.17-32.10%
2024-0.26-37.78%
2023-0.41-14.08%
2022-0.48-67.67%
2021-1.48-73.39%
2020-5.56N/A

Comparison Galecto (GLTO) P/E with competitors

Galecto (GLTO) P/E is -0.23.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.73%
NBYStablecoin Development Corp0.00-101.85%
ENLVEnlivex Ltd0.07-132.23%
FGENFibroGen Inc0.24-203.42%
CHRSCoherus Biosciences Inc0.85-465.60%
FBIOFortress Biotech Inc0.95-508.90%
ORMPOramed Pharmaceuticals Inc1.50-747.60%
AGENAgenus Inc3.01-1396.71%
INVAInnoviva Inc3.15-1458.93%
VXRTVaxart Inc3.55-1629.43%
CRMDCorMedix Inc3.63-1663.34%
CVACCureVac N.V.4.45-2015.45%
SRPTSarepta Therapeutics Inc4.88-2203.48%
ABEOAbeona Therapeutics Inc5.39-2421.24%
ABUSArbutus Biopharma Corp5.60-2510.91%
ZVRAZevra Therapeutics Inc5.89-2636.55%
SPROSpero Therapeutics Inc6.23-2783.57%
CGENCompugen Ltd6.31-2820.41%
RIGLRigel Pharmaceuticals6.87-3060.88%
SLXNSilexion Therapeutics Corp7.30-3243.57%
OMEROmeros Corporation9.26-4089.20%
AUPHAurinia Pharmaceuticals Inc9.58-4229.75%
PLXProtalix BioTherapeutics Inc10.89-4792.47%
ACADAcadia Pharmaceuticals Inc11.73-5153.33%
TBPHTheravance Biopharma Inc12.26-5383.24%
ADMAAdma Biologics Inc12.42-5450.46%
HRMYHarmony Biosciences Holdings Inc13.82-6054.54%
SABSSAB Biotherapeutics Inc14.14-6190.70%
NAGENiagen Bioscience Inc14.82-6484.51%
INCYIncyte Corp15.82-6917.28%
REGNRegeneron Pharmaceuticals Inc15.86-6931.97%
PBYIPuma Biotechnology Inc17.32-7560.62%
CPRXCatalyst Pharmaceuticals Inc17.44-7613.87%
EXELExelixis Inc17.54-7656.40%
TGTXTG Therapeutics Inc18.97-8271.69%
MDXGMimedx Group Inc20.55-8955.22%
XOMAXOMA Royalty Corp22.87-9956.01%
ARGXArgen X SE24.30-10569.28%
CTMXCytomX Therapeutics Inc24.82-10794.67%
XOMAOXOMA Royalty Corp25.34-11020.31%
HALOHalozyme Therapeutics Inc25.62-11140.48%
XOMAPXOMA Royalty Corp25.67-11160.48%
VRTXVertex Pharmaceuticals Inc27.99-12162.09%
RPRXRoyalty Pharma plc - Class A28.69-12460.59%
SLNOSoleno Therapeutics Inc29.02-12601.84%
ASNDAscendis Pharma A/S30.09-13062.96%
LGNDLigand Pharmaceuticals Inc - Class B37.91-16435.14%
APLSApellis Pharmaceuticals Inc39.02-16913.07%
BMRNBiomarin Pharmaceutical Inc42.21-18287.81%
KRYSKrystal Biotech Inc45.34-19637.14%
ONCBeiGene Ltd69.54-30062.89%
PHARPharming Group N.V.75.03-32426.28%
TECHBio-Techne Corp101.96-44030.82%
VCELVericel Corp109.92-47461.82%
ALNYAlnylam Pharmaceuticals Inc117.96-50927.64%
GMABGenmab140.29-60547.10%
TLXTelix Pharmaceuticals Ltd162.15-69966.81%
CORTCorcept Therapeutics Inc212.86-91813.95%